Trial intelligence / Profile preview

Preoperative Anemia and Iron Deficiency Treatment in Cardiac Surgery

NCT02031289Phase 4Completed

Sponsor
University of Zurich
Start
Dec 2013
Primary completion
Dec 2017
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of epoetin alfa, ferric carboxymaltose, vitamin b12, folic acid in anemia, iron deficiency anemia (IDA), sponsored by University of Zurich. Started Dec 2013; status: completed.

02

Drugs

epoetin alfaferric carboxymaltosevitamin b12folic acid
03

Conditions

anemiairon deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT02031289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02031289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call